GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $318,000 | +404.8% | 1,460 | +192.0% | 0.00% | – |
| Q4 2020 | $63,000 | 0.0% | 500 | -24.2% | 0.00% | – |
| Q3 2020 | $63,000 | -99.0% | 660 | -98.7% | 0.00% | -100.0% |
| Q2 2020 | $6,483,000 | +3977.4% | 50,597 | +2595.6% | 0.01% | – |
| Q1 2020 | $159,000 | -97.1% | 1,877 | -96.5% | 0.00% | -100.0% |
| Q4 2019 | $5,565,000 | -5.4% | 53,218 | +4.1% | 0.00% | -20.0% |
| Q3 2019 | $5,881,000 | -60.4% | 51,118 | -40.7% | 0.01% | -61.5% |
| Q2 2019 | $14,853,000 | +63.2% | 86,158 | +59.5% | 0.01% | +62.5% |
| Q1 2019 | $9,103,000 | -8.3% | 54,007 | -47.0% | 0.01% | -20.0% |
| Q4 2018 | $9,930,000 | -48.6% | 101,949 | -8.9% | 0.01% | -33.3% |
| Q3 2018 | $19,326,000 | +7508.7% | 111,875 | +6030.1% | 0.02% | – |
| Q2 2018 | $254,000 | +24.5% | 1,825 | +0.6% | 0.00% | – |
| Q1 2018 | $204,000 | -41.2% | 1,815 | -30.9% | 0.00% | – |
| Q4 2017 | $347,000 | +78.9% | 2,625 | +37.1% | 0.00% | – |
| Q3 2017 | $194,000 | -1.0% | 1,915 | -2.2% | 0.00% | – |
| Q2 2017 | $196,000 | -35.7% | 1,959 | -22.2% | 0.00% | – |
| Q1 2017 | $305,000 | +2672.7% | 2,519 | +2419.0% | 0.00% | – |
| Q4 2016 | $11,000 | -15.4% | 100 | 0.0% | 0.00% | – |
| Q3 2016 | $13,000 | +44.4% | 100 | 0.0% | 0.00% | – |
| Q2 2016 | $9,000 | +28.6% | 100 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | -95.7% | 100 | -95.7% | 0.00% | – |
| Q4 2015 | $161,000 | -20.7% | 2,320 | +4.5% | 0.00% | – |
| Q3 2015 | $203,000 | -25.6% | 2,220 | 0.0% | 0.00% | – |
| Q2 2015 | $273,000 | +17.7% | 2,220 | -12.9% | 0.00% | – |
| Q1 2015 | $232,000 | +34.1% | 2,550 | 0.0% | 0.00% | – |
| Q4 2014 | $173,000 | -16.0% | 2,550 | 0.0% | 0.00% | – |
| Q3 2014 | $206,000 | -27.5% | 2,550 | -3.8% | 0.00% | – |
| Q2 2014 | $284,000 | +4633.3% | 2,650 | +2550.0% | 0.00% | – |
| Q1 2014 | $6,000 | +50.0% | 100 | 0.0% | 0.00% | – |
| Q4 2013 | $4,000 | +100.0% | 100 | 0.0% | 0.00% | – |
| Q3 2013 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | – |
| Q2 2013 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |